Talphera (TLPH) Competitors $0.50 -0.01 (-1.87%) As of 09:57 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TLPH vs. LIAN, ITRM, XLO, OKUR, MDCX, KPTI, ESLA, ELYM, PLUR, and ACRVShould you be buying Talphera stock or one of its competitors? The main competitors of Talphera include LianBio (LIAN), Iterum Therapeutics (ITRM), Xilio Therapeutics (XLO), OnKure Therapeutics (OKUR), Medicus Pharma (MDCX), Karyopharm Therapeutics (KPTI), Estrella Immunopharma (ESLA), Eliem Therapeutics (ELYM), Pluri (PLUR), and Acrivon Therapeutics (ACRV). These companies are all part of the "pharmaceutical products" industry. Talphera vs. Its Competitors LianBio Iterum Therapeutics Xilio Therapeutics OnKure Therapeutics Medicus Pharma Karyopharm Therapeutics Estrella Immunopharma Eliem Therapeutics Pluri Acrivon Therapeutics LianBio (NASDAQ:LIAN) and Talphera (NASDAQ:TLPH) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, media sentiment, analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings. Does the MarketBeat Community believe in LIAN or TLPH? Talphera received 6 more outperform votes than LianBio when rated by MarketBeat users. Likewise, 100.00% of users gave Talphera an outperform vote while only 36.36% of users gave LianBio an outperform vote. CompanyUnderperformOutperformLianBioOutperform Votes436.36% Underperform Votes763.64% TalpheraOutperform Votes10100.00% Underperform VotesNo Votes Which has preferable earnings & valuation, LIAN or TLPH? Talphera has higher revenue and earnings than LianBio. Talphera is trading at a lower price-to-earnings ratio than LianBio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLianBioN/AN/A-$110.29M-$0.81-0.46Talphera$27K378.93-$18.40M-$0.45-1.11 Do analysts recommend LIAN or TLPH? Talphera has a consensus target price of $5.00, suggesting a potential upside of 902.00%. Given Talphera's stronger consensus rating and higher possible upside, analysts clearly believe Talphera is more favorable than LianBio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LianBio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Talphera 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50 Does the media favor LIAN or TLPH? In the previous week, Talphera had 2 more articles in the media than LianBio. MarketBeat recorded 2 mentions for Talphera and 0 mentions for LianBio. Talphera's average media sentiment score of 0.94 beat LianBio's score of 0.00 indicating that Talphera is being referred to more favorably in the news media. Company Overall Sentiment LianBio Neutral Talphera Positive Do insiders and institutionals have more ownership in LIAN or TLPH? 74.8% of LianBio shares are held by institutional investors. Comparatively, 37.7% of Talphera shares are held by institutional investors. 7.6% of LianBio shares are held by company insiders. Comparatively, 3.2% of Talphera shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is LIAN or TLPH more profitable? LianBio's return on equity of -33.17% beat Talphera's return on equity.Company Net Margins Return on Equity Return on Assets LianBioN/A -33.17% -30.19% Talphera N/A -118.46%-65.82% Which has more risk & volatility, LIAN or TLPH? LianBio has a beta of 0.23, meaning that its stock price is 77% less volatile than the S&P 500. Comparatively, Talphera has a beta of -0.11, meaning that its stock price is 111% less volatile than the S&P 500. SummaryTalphera beats LianBio on 11 of the 17 factors compared between the two stocks. Get Talphera News Delivered to You Automatically Sign up to receive the latest news and ratings for TLPH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TLPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLPH vs. The Competition Export to ExcelMetricTalpheraPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.23M$6.89B$5.59B$8.53BDividend YieldN/A2.54%5.28%4.17%P/E Ratio-0.728.5927.1019.77Price / Sales378.93261.29415.45154.58Price / CashN/A65.8538.3234.64Price / Book0.606.527.064.63Net Income-$18.40M$143.75M$3.24B$248.14M7 Day Performance-2.16%-0.56%-0.23%-0.35%1 Month Performance-4.02%10.58%8.59%4.28%1 Year Performance-49.08%3.13%32.13%13.39% Talphera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLPHTalphera2.5014 of 5 stars$0.50-1.9%$5.00+902.0%-48.3%$10.23M$27K-0.7219Gap DownLIANLianBioN/A$0.36flatN/A+15.3%$38.90MN/A-0.44110ITRMIterum Therapeutics2.4506 of 5 stars$0.97-3.0%$9.00+827.9%-17.0%$38.80MN/A-0.7410Analyst RevisionXLOXilio Therapeutics3.5736 of 5 stars$0.70-34.6%$4.00+471.3%-35.5%$36.25M$9.27M-0.4170Positive NewsShort Interest ↓Gap DownHigh Trading VolumeOKUROnKure Therapeutics3.3782 of 5 stars$2.65+4.7%$32.33+1,120.1%N/A$35.80MN/A-0.22N/ANews CoverageMDCXMedicus Pharma1.9966 of 5 stars$2.63+3.1%$23.50+793.5%N/A$35.70MN/A0.00N/AHigh Trading VolumeKPTIKaryopharm Therapeutics4.043 of 5 stars$4.12-1.9%$43.20+948.5%-71.8%$35.60M$142.13M-4.04380ESLAEstrella Immunopharma2.1537 of 5 stars$0.98-2.9%$16.00+1,532.7%+9.1%$35.44MN/A-3.77N/AShort Interest ↑Gap DownELYMEliem TherapeuticsN/A$1.18-3.3%N/A-85.2%$35.11MN/A-2.239PLURPluri2.2971 of 5 stars$4.47+0.2%$12.00+168.5%-24.8%$35.01M$1.03M-0.80150Short Interest ↑Gap DownACRVAcrivon Therapeutics4.2657 of 5 stars$1.11+5.7%$17.71+1,495.9%-83.2%$34.80MN/A-0.4158News CoveragePositive NewsAnalyst RevisionGap DownHigh Trading Volume Related Companies and Tools Related Companies LianBio Alternatives Iterum Therapeutics Alternatives Xilio Therapeutics Alternatives OnKure Therapeutics Alternatives Medicus Pharma Alternatives Karyopharm Therapeutics Alternatives Estrella Immunopharma Alternatives Eliem Therapeutics Alternatives Pluri Alternatives Acrivon Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TLPH) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talphera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talphera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TLPH Stock Free TLPH Stock Alerts